Randi J Hagerman Selected Research

5' Untranslated Regions (5' UTR)

9/2021	FMRP Levels in Human Peripheral Blood Leukocytes Correlates with Intellectual Disability.
8/2021	Brain Atrophy and White Matter Damage Linked to Peripheral Bioenergetic Deficits in the Neurodegenerative Disease FXTAS.
1/2019	New Targeted Treatments for Fragile X Syndrome.
1/2019	Association between IQ and FMR1 protein (FMRP) across the spectrum of CGG repeat expansions.
1/2016	Fragile X-associated tremor/ataxia syndrome - features, mechanisms and management.
11/2014	Fragile X spectrum disorders.
6/2014	Group I metabotropic glutamate receptor mediated dynamic immune dysfunction in children with fragile X syndrome.
1/2014	Genomic studies in fragile X premutation carriers.
2/2013	FRAGILE X SYNDROME: PSYCHIATRIC MANIFESTATIONS, ASSESSMENT AND EMERGING THERAPIES.
1/2013	Sequencing the unsequenceable: expanded CGG-repeat alleles of the fragile X gene.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Randi J Hagerman Research Topics

Disease

50	Fragile X Tremor Ataxia Syndrome 05/2022 - 01/2004
36	Fragile X Syndrome (Martin Bell Syndrome) 12/2020 - 01/2004
35	Intellectual Disability (Idiocy) 09/2021 - 12/2002
11	Autistic Disorder (Autism) 05/2021 - 02/2006
9	Neurodegenerative Diseases (Neurodegenerative Disease) 08/2021 - 01/2007
8	Autism Spectrum Disorder 12/2020 - 04/2009
6	Cognitive Dysfunction 01/2022 - 10/2003
6	Tremor (Tremors) 01/2021 - 02/2006
4	Neurodevelopmental Disorders 01/2022 - 12/2004
4	Ataxia (Dyssynergia) 01/2021 - 02/2006
3	Leukoencephalopathies 01/2021 - 02/2006
2	Mitochondrial Diseases (Mitochondrial Disease) 05/2021 - 06/2020
2	Primary Ovarian Insufficiency 01/2021 - 01/2020
2	Disease Progression 01/2021 - 06/2011
2	Inborn Genetic Diseases (Disease, Hereditary) 12/2020 - 01/2016
2	Type 2 Diabetes Mellitus (MODY) 11/2019 - 01/2019
2	Obesity 11/2019 - 11/2016
2	Peripheral Nervous System Diseases (PNS Diseases) 05/2019 - 02/2006
2	Mental Disorders (Mental Disorder) 01/2018 - 11/2005
2	Psychotic Disorders (Schizoaffective Disorder) 01/2018 - 08/2015
2	Seizures (Absence Seizure) 01/2018 - 01/2009
2	Sleep Apnea Syndromes (Sleep Apnea) 11/2016 - 12/2011
2	Alzheimer Disease (Alzheimer's Disease) 11/2014 - 03/2014
2	Parkinsonian Disorders (Parkinsonism) 04/2014 - 10/2006
2	Atrophy 08/2013 - 02/2006
2	Movement Disorders (Movement Disorder) 10/2006 - 01/2003
1	Clinical Deterioration 05/2020
1	Inflammation (Inflammations) 01/2020
1	Glucose Intolerance 11/2019
1	Nervous System Trauma 05/2019
1	Flatfoot (Flat Feet) 01/2018
1	Hallucinations (Hallucination) 01/2018
1	Neurologic Gait Disorders (Gait, Hemiplegic) 01/2018
1	Hypertension (High Blood Pressure) 11/2016
1	Dementia (Dementias) 11/2016
1	Hyperlipidemias (Hyperlipidemia) 11/2016
1	Hypothyroidism 11/2016
1	Epilepsy (Aura) 01/2016
1	Tuberous Sclerosis (Bourneville's Disease) 01/2016
1	Catatonia 08/2015

Drug/Important Bio-Agent (IBA)

27	Messenger RNA (mRNA)IBA 01/2021 - 01/2003
19	Proteins (Proteins, Gene)FDA Link 01/2022 - 01/2003
13	5' Untranslated Regions (5' UTR)IBA 09/2021 - 12/2002
8	RNA (Ribonucleic Acid)IBA 01/2021 - 02/2006
8	Fragile X Mental Retardation ProteinIBA 12/2020 - 01/2003
6	Biomarkers (Surrogate Marker)IBA 05/2022 - 06/2008
5	Pharmaceutical PreparationsIBA 11/2019 - 10/2012
4	GuanineIBA 01/2022 - 01/2004
4	IronIBA 01/2022 - 08/2013
4	CytosineIBA 01/2022 - 01/2004
4	gamma-Aminobutyric Acid (GABA)IBA 05/2019 - 09/2012
4	Sertraline (Zoloft)FDA LinkGeneric 01/2019 - 01/2012
4	Metabotropic Glutamate 5 ReceptorIBA 01/2018 - 01/2009
4	Memantine (Namenda)FDA Link 02/2016 - 10/2010
3	DNA (Deoxyribonucleic Acid)IBA 05/2020 - 07/2007
3	Selective Serotonin Reuptake Inhibitors (Serotonin Reuptake Inhibitors)IBA 01/2019 - 10/2016
3	ganaxoloneIBA 08/2017 - 01/2015
3	ElementsIBA 07/2015 - 04/2013
3	Minocycline (Cyclops)FDA LinkGeneric 08/2013 - 09/2010
2	ProteomeIBA 01/2021 - 01/2020
2	Amyloid (Amyloid Fibrils)IBA 01/2021 - 01/2021
2	Peptides (Polypeptides)IBA 01/2020 - 01/2019
2	Metformin (Glucophage)FDA LinkGeneric 11/2019 - 01/2019
2	NeurosteroidsIBA 05/2019 - 01/2016
2	Pregnanolone (Allopregnanolone)IBA 05/2019 - 01/2015
2	mavoglurantIBA 01/2019 - 01/2011
2	Serotonin (5 Hydroxytryptamine)IBA 06/2017 - 11/2014
2	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 11/2014 - 03/2014
2	Glutamic Acid (Glutamate)FDA Link 11/2014 - 05/2014
2	Lamin Type A (Lamin A)IBA 01/2010 - 10/2007
1	Ketoglutaric Acids (Ketoglutaric Acid)IBA 05/2021
1	Serine (L-Serine)FDA Link 05/2021
1	AntioxidantsIBA 01/2021
1	ApolipoproteinsIBA 01/2021
1	Apolipoproteins E (ApoE)IBA 01/2021
1	UbiquitinIBA 01/2021
1	sulforaphaneIBA 01/2021
1	PhytochemicalsIBA 01/2021
1	tau Proteins (tau Protein)IBA 01/2021
1	Patched-1 ReceptorIBA 12/2020
1	phosphoserine aminotransferase (phosphoserine transaminase)IBA 01/2020
1	TenascinIBA 01/2020
1	BiguanidesIBA 01/2019
1	RNA-Binding Proteins (RNA-Binding Protein)IBA 01/2019
1	2- chloro- 4- (1- (4- fluorophenyl)- 2,5- dimethyl- 1H- imidazol- 4- ylethynyl)pyridineIBA 01/2018
1	Dihydrotachysterol (AT 10)IBA 01/2018
1	Nonsense Codon (Nonsense Mutation)IBA 01/2018
1	Neurotransmitter Agents (Neurotransmitter)IBA 06/2017
1	Opioid Analgesics (Opioids)IBA 11/2016
1	BenzodiazepinesIBA 11/2016
1	N-Methylaspartate (NMDA)IBA 02/2016
1	trans-sodium crocetinate (crocetin)IBA 01/2016
1	Anticonvulsants (Antiepileptic Drugs)IBA 01/2016
1	Anti-Anxiety Agents (Anxiolytics)IBA 01/2016
1	Narcotics (Narcotic Analgesics)IBA 06/2015
1	Methadone (Dolophine)FDA LinkGeneric 06/2015
1	Opiate AlkaloidsIBA 11/2014

Therapy/Procedure

5	Therapeutics 02/2016 - 10/2006
2	General Anesthesia 05/2020 - 11/2016
1	Precision Medicine 05/2019